Liver Cancer and PFAS Exposure

Do I have a liver cancer PFAS claim?

There is no way to answer that from a web page alone, but these are the facts a Pennsylvania liver cancer PFAS claim review actually turns on. If most of them describe your situation, it is worth submitting the intake form.

• A confirmed liver cancer diagnosis, documented by pathology or an oncology record.
• A PFAS exposure source you can point to — a public water system, a private well, AFFF firefighting foam, a military base, an airport, or an industrial workplace.
• Time spent at that location: where you lived, worked, or served, and roughly which years.
• Diagnosis timing that follows the exposure period, which is what links the two in a claim review.
• Any supporting paperwork — water-test results, utility bills, employment records, or military service records tying you to the location.

Representation of accepted cases is typically on a contingency-fee basis — no attorneys’ fees unless a recovery is obtained. Clients may remain responsible for case costs and expenses; the written retainer will set out how costs are handled. No case outcome is guaranteed.

PFAS linkage

• The liver is a primary organ for toxicology research involving PFAS, with studies reporting associations with liver enzymes, fatty liver markers, and metabolic changes.
• Some studies have examined PFAS exposure and liver cancer risk, particularly in relation to long-term body burden and liver injury pathways.
• Because liver cancer has several established causes, intake review requires detailed medical and exposure documentation.

Liver cancer symptoms

• Unexplained weight loss or loss of appetite
• Upper abdominal pain, swelling, or a feeling of fullness
• Yellowing of the skin or eyes
• Nausea, vomiting, fatigue, or weakness
• Easy bruising, dark urine, pale stools, or worsening liver disease symptoms

Diagnosis and medical records

• Blood tests including liver function tests and AFP when appropriate
• Ultrasound, CT, MRI, or contrast-enhanced imaging of the liver
• Biopsy in selected cases when imaging and blood tests are not definitive
• Staging tests to assess liver function, tumor burden, and spread

Treatment options

• Surgical resection or liver transplant for selected localized cases
• Ablation, embolization, chemoembolization, or radioembolization
• Immunotherapy, targeted therapy, or systemic therapy for advanced disease
• Supportive care to manage cirrhosis, pain, nutrition, or bile-duct complications

What patients should gather for intake

• Keep imaging reports, biopsy or pathology results, AFP levels, liver-function records, and oncology summaries.
• Include history of hepatitis, cirrhosis, fatty liver disease, alcohol-related liver disease, or transplant evaluation.
• Document PFAS exposure sources, especially long-term contaminated water or occupational contact.